Elisberg Industries
  • Home
  • Blog
  • Products
    • Books
    • Movies
  • About Elisberg Industries
    • Our Corporate Board
    • Information Overstock
    • Elisberg Industries Entertainment Information
    • Elisberg Statistical Center of American Research
    • Consultancy Service
  • Contact
    • How to Find Us
  • Kudos
  • Good Things to Know
    • The BOB Page
    • Sites You Might Actually Like
Decent Quality Since 1847

Today's Adorable Animal Video

4/29/2020

0 Comments

 
​

Baby mini horse grows up snuggling on the sofa □□@dodo pic.twitter.com/zHfWKK4ovC

— Nguyen #fbpe #fbr (@haaohaoo) April 29, 2020
0 Comments

Flattening Themselves

4/29/2020

0 Comments

 
A couple weeks ago, I wrote here about how one of the most stupid political moves Trump has made is that when the early models suggested there could be between 120,000-240,000 deaths of Americans, Trump jumped on the "good news" of a new model that suggested it could instead "only" be 60,000 deaths -- more than Americans who died in Viet Nam.  It sounded better, so he could announce it as "good news."  The problem was that he created a lower standard that it would be far easier to go over.  And then he made it worse by saying that "I heard 50," that it could be as "low" as 50,000 deaths, because that sounded "better."  Never thinking that that lower standard would be the new one he'd be judged by -- and he did even foolishly say these were the standards he should be judged by.  Fair enough, fine by me.

(What Trump always ignored, in his blindness for "good news" is that ALL these projections were based on Best Case Scenario, where everything went right.  Where everyone wore facemasks, where everyone social distanced, where there were enough ventilators and PPEs in hospitals, and where all businesses stayed closed until it was the curve hand flattened and started to go down.  But Trump has down most everything possible to ensure that the Best Case Scenario was a chimera.  And set that 50,000 mark as his standard to be judged by.  Fair enough, fine by me.)

The reality is that we're now well-past that 50,000 death standard, and as I write this on Tuesday night, we're at the 59,000 mark. Okay, to be fair, 58,955.  But then, to be totally fair, by the time you read this on Wednesday, it could be nearing that 60,000 level.

And will soon be soaring past.  Consider:  we are still getting 1,500-2,000 deaths every day.  In fact, that organization that put out the 60,000 model has just readjusted it, and now made their guess to be 74,000 deaths.  But, doing easy math, if we're getting 2,000 deaths a day...we'll be at that 74,000 figure in one week!  And flying past it.

For instance, another thing to consider:  while some places, like perhaps New York and California, may possibly be dropping down a bit -- perhaps -- (and those are major places to drop) quite a few Red states have re-opened some of their their business, Florida re-opened its beaches, meat-packing plants with growing levels of infections are re-opening, and Las Vegas is on the verge of re-opening its casinos (pushed strongly by Trump who, oh, by the way, has a casino hotel there).  The number of deaths each day tragically may not only not lower, but could go up.  

And this doesn't consider the second wave that pretty much all experts are saying will be coming in the fall.  (Before the election.)

But the curve is flattening, many Republicans are shouting.  The end is in slight.  Go forth and prosper.

Forgetting for the moment that this might not be truth, let's accept for the sake of argument.  Let's say that the curve is indeed flattening.  Which, if so, is indeed good.  And yes, that means the end is in "sight" -- except that doesn't mean "near."  The horizon is in sight.  The moon is in sight.  They're still very far off.

Consider, again:  just because the curve is flattening -- if it is -- doesn't mean it will be starting a downturn tomorrow.  The level could be flat for weeks.  Or a month.  Or longer.  Further, as scientists keep trying to make clear, the first day that the curve starts down from its peak...that number will be the second most deaths in a day we will have had.

(Well, okay, sort of.  A flattened curve isn't a steady flat one.  It has ups and down along along a basically standard pace.  But the general point holds:  the day the curve starts to go down, it's from it's high point, and the number of deaths will still be very high.)

And then it's not like the downturn will last a few days, and then it will be gone...like the proverbial Trump "miracle."  That downturn could last months, and probably will.  Until that second wave comes.

Indeed, we may look back that that Trump standard of 50,000 deaths as quaint.

Will it hit the initial 120,000-240,000 range?  Probably not, hopefully not (though reality demands saying possibly so).  But it seems likely to my totally untrained eye that the number of deaths from the coronavirus -- by the time there is a vaccine for everyone, and life has become a reasonable version of life again -- will be a lot closer to that horrific 120,000 than to the Trump standard of 50,000.  After all, we could be at 75,000 to 80,000 deaths by next Saturday.

Yes, the number of deaths of American men and women is horrific.  But there are reports of progress made on vaccines and treatments.  However, even the absolute best of those reports is five months away, and only enough could be produced for a part of the world population.  Other solutions are still a year away, or longer.  But it will come.

The larger point is that Trump and Republicans are looking at all this without the focus of reality.  And it's not just that the number of American deaths is going to be far worse than what they are trying to convince their base and the American publican, but in trying to make that false case by believing their own fantasies, they are creating a bridge to their own disastrous failure.  They are seemingly doing everything possible not to flatten the curve, and in doing so they are only serving to flatten themselves.

Because in the end, this is not about Trump.  This is about the elected members of the Republican Party -- in Congress and throughout the states -- who enable him, follow his actions, and are complicit.
0 Comments

Take Two

4/28/2020

0 Comments

 
To anyone who tuned in on Sunday night to watch that Stephen Sondheim 90th birthday gala, as you no doubt noticed, they had major technical problems last night.  After waiting for a half hour, the feed ended, and I gave up and returned to my regularly-schedule evening.. 
 
As it turns out, in the end, they finally resolved the issues and did the broadcast.  And it’s available at the same place to watch – on their YouTube channel here.  Better still, if you have a SmartTV, you can go to the YouTube app and watch it on the "Broadwaycom" channel.  .And since it’s now recorded and not streaming live, you don’t have to watch it all at once, if it’s too long – and it is long, almost 2-1/2 hours.
 
Or to make it easiest of all, I've embedded it below.

Curtain up.
0 Comments

Testing Addendum

4/28/2020

0 Comments

 
Related to my piece this morning about tests for a COVID-19 vaccine, there are also reports of very early tests (very early) for a possible treatment using…Pepcid AC!  It’s not the heartburn medication itself they’re interested in, but the active drug it uses, famotidine.  It’s a cheaper drug than what’s used in Prilosec, and researchers in China found that people who live in poorer areas had a death rate of 14%, while richer areas were 27%.   And since heartburn seemed to be a symptom of the condition, the poorer areas were using Pepcid AC (which costs less), while the richer areas were using the more expensive Prilosec.  That got researchers the idea to test what might be going on.  The thinking is that famotidine may combine with a COVID-19 pathogen and block it.  But studies are in the extremely early stages.  The plus side is that famotidine is an approved drug without any serious side effects when used properly.  The only concerns of scientists are that 1) there could be a run on Pepcid and generics (which there was been, they're largely sold out on Amazon), leaving a shortage for those who need it – or for scientists so that it can be tested, and 2) that people don’t take it as recommended and overuse it would could cause problems for them.

And to be clear, this is for something that would be a treatment for those who have already contracted the coronavirus, not a vaccine to prevent infection.
0 Comments

A Test of Honey

4/28/2020

0 Comments

 
There was an encouraging article in yesterday's New York Times by David D. Kirkpatrick about an Oxford research group that has made important strides in testing a coronavirus vaccine.  You can find the article here.  (I've liked the the article posted with the Seattle Times, since the New York Times only allows a limited amount of free access, and some people may have exceeded that.)

Among the things that the story notes is that the team has had a slight head-start on other research due to past research projects they've done on other coronavirus vaccines.  In this case, they are at the point where they tested their vaccine on six rhesus macaque monkeys -- a type of monkey that's closest to humans -- and then exposed them to heavy quantities of the virus...and none have have contracted the disease.  Similarly, they have previous exposed 28 monkeys to the same virus, but without the vaccine, and all showed symptoms.

Much more clinical testing is needed, particularly on humans to determine both the safety and efficacy of the vaccine.  But if all goes well, then conceivably it could pass approval as early as late September.  They have already scheduled clinical tests on over 6,000 people by the end of next month.

“'It is a very, very fast clinical program,' said Emilio Emini, a director of the vaccine program at the Bill and Melinda Gates Foundation, which is providing financial support to many competing efforts."

The article makes clear that it's still important that the other studies are continuing, if only to increase the pipeline for distributing a vaccine.  Also, it's likely that different vaccines could be needed for different groups of people -- the elderly or young, for instance.  What's also encouraging is that they say even if, in the end, this vaccine can get approved, so much has been learned about the nature of the coronavirus and of people's immune system towards it that this study's results will be very helpful to other research.

"All of the others will face the same challenges," the article reports, "including obtaining millions of dollars in funding, persuading regulators to approve human tests, demonstrating a vaccine’s safety and — after all of that — proving its effectiveness in protecting people from the coronavirus."

But it certainly appears to be an encouraging leap forward.
0 Comments

SGN:  Week 5

4/27/2020

0 Comments

 
John Krasinski is now 5 for 5 with his latest "Some Good News" broadcast.  We're now officially caught up, and so here's the latest.
​
0 Comments
<<Previous
Forward>>
    Picture
    Picture
    Elisberg Industries gets a commission if you click here before shopping on Amazon.
    Picture
    Follow @relisberg

    Author

    Robert J. Elisberg is a political commentator, screenwriter, novelist, tech writer and also some other things that I just tend to keep forgetting. 

    Elisberg is a two-time recipient of the Lucille Ball Award for comedy screenwriting. He's written for film, TV, the stage, and two best-selling novels, is a regular columnist for the Writers Guild of America and was for
    the Huffington Post.  Among his other writing, he has a long-time column on technology (which he sometimes understands), and co-wrote a book on world travel.  As a lyricist, he is a member of ASCAP, and has contributed to numerous publications.

    Picture
           Available on Amazon

    Picture
           Available on Amazon

    Picture
           Feedspot Badge of Honor

    Archives

    June 2025
    May 2025
    April 2025
    March 2025
    February 2025
    January 2025
    December 2024
    November 2024
    October 2024
    September 2024
    August 2024
    July 2024
    June 2024
    May 2024
    April 2024
    March 2024
    February 2024
    January 2024
    December 2023
    November 2023
    October 2023
    September 2023
    August 2023
    July 2023
    June 2023
    May 2023
    April 2023
    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013

    Categories

    All
    Animals
    Audio
    Audio Land
    Books
    Business
    Chicago
    Consumer Product
    Education
    Email Interview
    Entertainment
    Environment
    Fine Art
    Food
    From The Management
    Health
    History
    Huffery
    Humor
    International
    Internet
    Journalism
    Law
    Los Angeles
    Media
    Morning News Round Up
    Movies
    Music
    Musical
    Personal
    Photograph
    Piano Puzzler
    Politics
    Popular Culture
    Profiles
    Quote Of The Day
    Radio
    Religion
    Restaurants
    Science
    Sports
    Technology
    Tech Tip
    Theater
    The Writers Workbench
    Tidbits
    Travel
    Tv
    Twitter
    Video
    Videology
    Well Worth Reading
    Words-o-wisdom
    Writing

    RSS Feed

© Copyright Robert J. Elisberg 2025
Contact Us    About EI    Chicago Cubs
  • Home
  • Blog
  • Products
    • Books
    • Movies
  • About Elisberg Industries
    • Our Corporate Board
    • Information Overstock
    • Elisberg Industries Entertainment Information
    • Elisberg Statistical Center of American Research
    • Consultancy Service
  • Contact
    • How to Find Us
  • Kudos
  • Good Things to Know
    • The BOB Page
    • Sites You Might Actually Like